Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto, Bayer CropScience, Max Planck Settle IP Dispute Over Plant DNA Transfer Technology

NEW YORK, Feb. 4 (GenomeWeb News) - Monsanto, Bayer CropScience, the Max Planck Society, and Garching Innovation, Max Planck's technology transfer manager, have settled their patent dispute over a technology to transfer DNA into plant cells, the parties said today.

 

The technology, known as Agrobacterium transformation, is mainly used to create transgenic crops.

 

Under the agreement, Monsanto and Bayer CropScience, Max Planck's exclusive licensee, will grant each non-exclusive licenses to the technology in certain areas of the world related to the development, use, and sale of transgenic crops. Moreover, Monsanto will provide Max Planck with a license for research purposes in the US.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.